Alejandro Bernal - Zoetis President

ZTS -- USA Stock  

USD 119.64  1.38  1.14%

  President
Mr. Alejandro Bernal is Executive Vice President, Group President Strategy, Commercial and Business Development of Zoetis Inc. From October 2012 through April 2015 he served as our Executive Vice President and Area President of the Europe, Africa and Middle East region. He was Area President of the Europe, Africa and Middle East region for Pfizers animal health business unit from 2010 to 2012
Age: 43  President Since 2015  MBA    
973-822-7000  http://www.zoetis.com
Bernal joined Pfizer in 2000 and held various positions, including Area President of the Canada and Latin America region; Regional Director of Southwest and Central Latin America; Division Director for Central America and Colombia; Swine and Poultry Team Leader for Mexico; and Swine Product Manager for Northern Latin America for Pfizer Animal Health. Alejandro holds a doctorate in veterinary medicine from Universidad de Caldas, a master degree in physiology from Texas A&M University, and a MBA from Universidad de los Andes and Manchester Business School .

Management Efficiency

The company has Return on Asset of 12.56 % which means that on every $100 spent on asset it made $12.56 of profit. This is considered to be average in the sector. In the same way, it shows return on shareholders equity (ROE) of 62.6 % implying that it generated $62.6 on every 100 dollars invested.
The company has 6.65B in debt with debt to equity (D/E) ratio of 275.9 . This implies that the company may be unable to create cash to meet all of its financial commitments. Zoetis has Current Ratio of 4.09 demonstrating that it is liquid and is capable to disburse its financial commitments when the payables are due.

Similar Executives

Showing few of many executives

PRESIDENT Since

Peter PowchikRegeneron Pharmaceuticals
2006
Michael StewartPerrigo Company plc
2004
Douglas BoothePerrigo Company plc
2013
Jeffrey ChodakewitzVertex Pharmaceuticals Incorpor
2014
Charles WagnerVertex Pharmaceuticals Incorpor
2019
Amit SachdevVertex Pharmaceuticals Incorpor
2017
Jatin ShahPerrigo Company plc
2005
Michael PariniVertex Pharmaceuticals Incorpor
2017
Marion McCourtRegeneron Pharmaceuticals
2018
Ian SmithVertex Pharmaceuticals Incorpor
2017
John WesolowskiPerrigo Company plc
2016
Daniel PlewRegeneron Pharmaceuticals
2016
Umang VohraDr Reddys Laboratories Ltd
2013
Marc CouckePerrigo Company plc
N/A
John GrayVertex Pharmaceuticals Incorpor
2019
Svend AndersenPerrigo Company plc
2017
Grainne QuinnPerrigo Company plc
2016
Joseph LaRosaRegeneron Pharmaceuticals
2019
Saumen ChakrabortyDr Reddys Laboratories Ltd
2018
Ronald JanishPerrigo Company plc
2015
Thomas FarringtonPerrigo Company plc
2015

Entity Summary

Zoetis Inc. discovers, develops, manufactures, and commercializes animal health medicines, vaccines, and diagnostic products in the United States and internationally. The company was founded in 1952 and is headquartered in Parsippany, New Jersey. Zoetis operates under Drug Manufacturers - Specialty Generic classification in USA and is traded on BATS Exchange. It employs 10000 people.Zoetis (ZTS) is traded on BATS Exchange in USA and employs 10,000 people.

Zoetis Leadership Team

Roman Trawicki, Executive Vice President and Presidentident of Global Manufacturing and Supply
Kristin Peck, Executive Vice President and Group President, U.S. Operations, Business Development and Strategy
William Steere, Independent Director
Roxanne Lagano, Executive Vice President, Chief Human Resources Officer and Communications
Linda Rhodes, Independent Director
Frank DAmelio, Independent Director
Robert Scully, Independent Director
Clinton Lewis, Executive Vice President and Group President, International Operations, Commercial Development, Global Genetics, Aquatic Health and Human Medical Diagnostics
Stefan Weiskopf, Executive Vice President and Area President of the Asia Pacific, Australia and New Zealand
Sanjay Khosla, Independent Director
Paul Herendeen, CFO and Executive VP
Catherine Knupp, Executive Vice President, President - Research and Development
Michael McCallister, Non-Executive Independent Chairman of the Board
Paul Bisaro, Independent Director
Alejandro Bernal, Executive Vice President and Area President of the Europe, Africa and Middle East region
Willie Reed, Independent Director
Joyce Lee, Executive Vice President and Area President of the Canada and Latin America region
Glenn David, Chief Financial Officer, Executive Vice President
Sandra Beaty, Executive Vice President - Corporate Affairs
William Doyle, Director
Andrew Fenton, Executive Vice President and Chief Digital and Technology Officer
Gregory Norden, Independent Director
Louise Parent, Independent Director
Heidi Chen, Executive Vice President General Counsel, Corporate Secretary
Juan Alaix, Chief Executive Officer, Director

Stock Performance Indicators

Current Sentiment - ZTS

Zoetis Investor Sentiment

Greater number of Macroaxis users are at this time bullish on Zoetis. What is your take regarding investing in Zoetis? Are you bullish or bearish?
Bullish
Bearish
98% Bullish
2% Bearish
Skip

Also Currentnly Active

Purchased over 20 shares of
1 hour ago
Traded for 135.34
Purchased a lot of shares of
1 hour ago
Traded for 155.87
Purchased over 70 shares of
1 hour ago
Traded for 35.56
See also Your Current Watchlist. Please also try Equity Analysis module to research over 250,000 global equities including funds, stocks and etfs to find investment opportunities.
Search macroaxis.com